Atlas Trials

A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

Clinical trial NCT00537485 · COMPLETED

Trial details

NCT number
NCT00537485
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Early Parkinson's Disease
Start date
2007-09-01
Primary completion
2009-12-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.